3. Respiratory system
3.11. Antifibrotics
Total Formulary

NINTEDANIB (OFEV) (capsules)
Restrictions: Restricted to specialist use for the treatment of adults with idiopathic pulmonary fibrosis (IPF) with a predicted forced vital capacity (FVC) of less than or equal to 80% where an Interstitial Lung Disease Multidisciplinary Team has agreed it is appropriate.

PIRFENIDONE (capsules)
Restrictions: Restricted to specialist use only in patients with a predicted forced vital capacity (FVC) less than or equal to 80% where an Interstitial Lung Disease Multidisciplinary Team has agreed it is appropriate.